Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, April 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

patent: 36 patents
f1000: 1 research highlight platform

Readers on

mendeley: 272 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 36 patents that reference this research output.

Catalysts and methods for enantioselective conjugate addition of amines to unsaturated…

Grant US-11840514-B2

United States of America

12 Dec 2023

Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-met…

Grant US-11427605-B2

United States of America

30 Aug 2022

PROCESS FOR MULTI-ANALYSES OF RARE CELLS EXTRACTED OR ISOLATED FROM BIOLOGICAL SAMPLES…

Application EP-3745126-A1

European Patent Office

02 Dec 2020

Catalysts and methods for enantioselective conjugate additions of amines to unsaturated…

Grant US-10781172-B2

United States of America

22 Sep 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 32 additional patents.